Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine

Ahmed, 2016, Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery, Drug Design, Development and Therapy, 10, 483, 10.2147/DDDT.S99651 Amidi, 2007, N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model, Vaccine, 25, 144, 10.1016/j.vaccine.2006.06.086 Aucouturier, 2001 Chen, 2010, Astragalus polysaccharide and oxymatrine can synergistically improve the immune efficacy of Newcastle disease vaccine in chicken, International Journal of Biological Macromolecules, 46, 425, 10.1016/j.ijbiomac.2010.02.004 Dai, 2015, O-2′-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine, Carbohydrate Polymers, 130, 280, 10.1016/j.carbpol.2015.05.008 Fan, 2015, Ophiopogon polysaccharide liposome can enhance the non-specific and specific immune response in chickens, Carbohydrate Polymers, 119, 219, 10.1016/j.carbpol.2014.11.048 Garcia-Fuentes, 2012, Chitosan-based drug nanocarriers: where do we stand?, Journal of Controlled Release, 161, 496, 10.1016/j.jconrel.2012.03.017 Ghendon, 2008, Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines, Archives of Virology, 153, 831, 10.1007/s00705-008-0047-4 Hagenaars, 2009, Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine, Journal of Controlled Release, 140, 126, 10.1016/j.jconrel.2009.08.018 Heegaard, 2011, Adjuvants and delivery systems in veterinary vaccinology: Current state and future developments, Archives of Virology, 156, 183, 10.1007/s00705-010-0863-1 Homhuan, 2004, Virosome and ISCOM vaccines against Newcastle disease: Preparation, characterization and immunogenicity, European Journal of Pharmaceutical Sciences, 22, 459, 10.1016/j.ejps.2004.05.005 Huang, 2008, Sulfated modification can enhance the adjuvant activity of astragalus polysaccharide for ND vaccine, Carbohydrate Polymers, 73, 303, 10.1016/j.carbpol.2007.11.032 Huo, 2010, Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug, International Journal of Pharmaceutics, 394, 162, 10.1016/j.ijpharm.2010.05.001 Illum, 2001, Chitosan as a novel nasal delivery system for vaccines, Advanced Drug Delivery Reviews, 51, 81, 10.1016/S0169-409X(01)00171-5 Ko, 2002, Preparation and characterization of chitosan microparticles intended for controlled drug delivery, International Journal of Pharmaceutics, 249, 165, 10.1016/S0378-5173(02)00487-8 Kou, 2014, Differential effects of Naja naja atra venom on immune activity, Evidence-Based Complementary and Alternative Medicine, 12 Li, 2011, The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response, Biomaterials, 32, 469, 10.1016/j.biomaterials.2010.08.107 Liu, 2008, Molecular characterization and phylogenetic analysis of new Newcastle disease virus isolates from the mainland of China, Research in Veterinary Science, 85, 612, 10.1016/j.rvsc.2008.02.013 Liu, 2016, Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response, Carbohydrate Polymers, 142, 141, 10.1016/j.carbpol.2016.01.021 Lv, 2011, Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration, Biomacromolecules, 12, 4230, 10.1021/bm2010774 Man, 2006, Human cancer vaccines, Advanced Drug Delivery Reviews, 58, 899, 10.1016/j.addr.2006.08.001 No, 2007, Applications of chitosan for improvement of quality and shelf life of foods: A review, Journal of Food Science, 72, R87, 10.1111/j.1750-3841.2007.00383.x Ogra, 2001, Vaccination strategies for mucosal immune responses, Clinical Microbiology Reviews, 14, 10.1128/CMR.14.2.430-445.2001 Qiu, 2007, Immunopotentiating effects of four Chinese herbal polysaccharides administered at vaccination in chickens, Poultry Science, 86, 2530, 10.3382/ps.2007-00076 Radosevic, 2008, Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants, Vaccine, 26, 3640, 10.1016/j.vaccine.2008.04.071 Rauw, 2010, The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine, Veterinary Immunology and Immunopathology, 134, 249, 10.1016/j.vetimm.2009.10.028 Reed, 2009, New horizons in adjuvants for vaccine development, Trends in Immunology, 30, 23, 10.1016/j.it.2008.09.006 Reed, 2013, Key roles of adjuvants in modern vaccines, Nature Medicine, 19, 1597, 10.1038/nm.3409 Reynolds, 2000, Protective immunity against Newcastle disease: The role of antibodies specific to Newcastle disease virus polypeptides, Avian Diseases, 44, 138, 10.2307/1592517 Sachan, 2015, Adjuvant potential of resiquimod with inactivated Newcastle disease vaccine and its mechanism of action in chicken, Vaccine, 33, 4526, 10.1016/j.vaccine.2015.07.016 Sahni, 2008, Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: Synthesis, characterization and applications, The Journal of Pharmacy and Pharmacology, 60, 1111, 10.1211/jpp.60.9.0001 Scherliess, 2013, In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations, Vaccine, 31, 4812, 10.1016/j.vaccine.2013.07.081 Schirmbeck, 1994, Immunization with soluble hepatitis-B virus surface protein elicits murine H-2 class-I-restricted CD8+ cytotoxic t-lymphocyte responses in-vivo, The Journal of Immunology, 152, 1110, 10.4049/jimmunol.152.3.1110 Sinani, 2019, Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination, International Journal of Pharmaceutics, 10.1016/j.ijpharm.2019.118592 Singh, 2007, Nanoparticles and microparticles as vaccine delivery systems, Expert Review of Vaccines, 6, 797, 10.1586/14760584.6.5.797 Slütter, 2009, Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination, Journal of Controlled Release, 138, 113, 10.1016/j.jconrel.2009.05.011 Smith, 2015, Nanoparticles as synthetic vaccines, Current Opinion in Biotechnology, 34, 217, 10.1016/j.copbio.2015.03.014 Spickler, 2003, Adjuvants in veterinary vaccines: Modes of action and adverse effects, Journal of Veterinary Internal Medicine, 17, 273, 10.1111/j.1939-1676.2003.tb02448.x Summerfield, 1996, Functional characterization of porcine CD4(+)CD8(+) extrathymic T lymphocytes, Cellular Immunology, 168, 291, 10.1006/cimm.1996.0078 Svindland, 2012, The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine, Influenza and Other Respiratory Viruses, 6, 90, 10.1111/j.1750-2659.2011.00271.x Svindland, 2013, A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine, Influenza and Other Respiratory Viruses, 7, 1181, 10.1111/irv.12056 Thekisoe, 2004, Different approaches to the vaccination of free ranging village chickens against Newcastle disease in Qwa-Qwa, South Africa, Veterinary Microbiology, 101, 23, 10.1016/j.vetmic.2004.03.011 Tretyakova, 2013, Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine, Vaccine, 31, 1019, 10.1016/j.vaccine.2012.12.050 Tseng, 2010, The influence of liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease, The Veterinary Journal, 185, 204, 10.1016/j.tvjl.2009.05.019 Wack, 2005, Vaccinology at the beginning of the 21st century, Current Opinion in Immunology, 17, 411, 10.1016/j.coi.2005.05.005 Wang, 2012, Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge, Archives of Virology, 157, 1451, 10.1007/s00705-012-1318-7 Weilhammer, 2013, The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge, Biomaterials, 34, 10305, 10.1016/j.biomaterials.2013.09.038 Wen, 2011, Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by Ovalbumin in mice, Marine Drugs, 9, 1038, 10.3390/md9061038 Xiang, 2006, Pathogen recognition and development of particulate vaccines: does size matter?, Methods, 40, 1, 10.1016/j.ymeth.2006.05.016 Yang, 2018, Immunostimulatory effects of sulfated chitosans on RAW 264.7 mouse macrophages via the activation of PI3K/Akt signaling pathway, International Journal of Biological Macromolecules, 108, 1310, 10.1016/j.ijbiomac.2017.11.042 Yang, 2019, Hydroxypropyltrimethyl ammonium chloride chitosan activates RAW 264.7 macrophages through the MAPK and JAK-STAT signaling pathways, Carbohydrate Polymers, 205, 401, 10.1016/j.carbpol.2018.10.101 Yousefi, 2019, Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?, Iranian Journal of Basic Medical Sciences, 22, 360 Zaharoff, 2007, Chitosan solution enhances the immunoadjuvant properties of GM-CSF, Vaccine, 25, 8673, 10.1016/j.vaccine.2007.10.037 Zhao, 2016, Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine, Carbohydrate Polymers, 149, 28, 10.1016/j.carbpol.2016.04.085 Zou, 2015, Preparation and drug release behavior of pH-responsive bovine serum albumin-loaded chitosan microspheres, Journal of Industrial and Engineering Chemistry, 21, 1389, 10.1016/j.jiec.2014.06.012